Given the following molecule represented by the SMILES string: CC[NH+](CC)CCNC(=O)c1cc(Cl)c(N)cc1OC, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The molecule has a complex structure with a positively charged amine group attached to a benzene ring (N+), indicating potential interactions with proteins that have specific binding sites for basic amino groups. This feature suggests the molecule could interact with receptors that bind to such groups.
Step 2: The presence of a carboxylate group (-COOH) and an ester linkage (C=O) suggests the molecule may be involved in processes requiring proton transfer or can act as a ligand for enzymes or receptors that recognize acidic functional groups. 
Step 3: The molecule contains multiple aromatic rings (benzene rings), which are common in many drugs and can form π-π stacking interactions with other molecules. These interactions are important for binding to protein targets like receptors and transporters.
Step 4: Given the complexity and functional groups present, this molecule could potentially interact with several drug targets including transporters, receptors, and enzymes encoded by the listed genes. However, without more detailed information about the specific pharmacological activity of the molecule, it's difficult to pinpoint exact genes it would interact with.
Step 5: Based on the structural features described, some genes that might be relevant include: CYP2D6 (cytochrome P450 enzyme involved in drug metabolism), CYP2C9 (another drug-metabolizing enzyme), CYP3A4 (a major drug-metabolizing enzyme), and SLC6A4 (a sodium-dependent serotonin transporter). Other possible candidates are HTR2A (serotonin receptor) and DRD2 (dopamine receptor).
Summary of Related Gene Names:
- CYP2D6
- CYP2C9
- CYP3A4
- SLC6A4
- HTR2A
- DRD2
Note: This analysis is based on general structural features and does not account for specific binding affinities or pharmacological activities of the molecule. For precise interactions, experimental data would be necessary. Step 1: The molecule has a positively charged nitrogen atom (N+), which can interact with negatively charged sites on proteins, suggesting potential binding to ion channels or receptors.
Step 2: The presence of multiple aromatic rings indicates the molecule could interact with proteins containing hydrophobic binding pockets, such as membrane proteins.
Step 3: The carboxylic acid group (-COOH) and ester functionality suggest the molecule might be involved in pH-dependent interactions or can bind to enzymes or receptors with specific acid-base properties.
Step 4: The overall structure hints at potential interactions with enzymes involved in drug metabolism, such as CYP enzymes (CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4).
Step 5: The molecule’s complexity and functional groups also point towards possible interactions with neurotransmitter receptors, particularly those related to serotonin (HTR1A, HTR2A, HTR2B, HTR2C) and dopamine (DRD2, DRD3, DRD4).
- CYP1A2
- CYP2C19
- HTR1A
- HTR2B
- HTR2C
- HTR6
